Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enalapril orodispersible minitablets in young children with heart failure due to congenital heart disease
NL-OMON45974Phase 2Active, not recruiting
- Sponsor
- Ethicare Clinical Trial Services
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of enalapril in heart failure (HF) and Cardiovascular Malformation (CVM) (2 arms), sponsored by Ethicare Clinical Trial Services. Primary endpoint: Enalapril and enalaprilat bioavailability. Started Dec 2016; status: active, not recruiting.
02
Drugs
enalapril
03
Conditions
heart failure (HF)Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on NL-OMON45974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45974.